Announced Thu, 16 Jul · 18:30 IST
ESOP grant of 2,07,003 stock options and RSUs to employees under 2018 plan
Management Changes View source PDF
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹1028.85
prior close
₹1017.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.6-0.3-1.2-0.4-2.3-3.8-5.4-6.0—————
Up moveDown movePending
AI summary
Jubilant Pharmova's Nomination, Remuneration and Compensation Committee approved grant of 2,07,003 Stock Options, RSUs and PSUs to eligible employees under the Jubilant Pharmova Employees Stock Option Plan 2018. Of these, 1,81,570 RSUs and PSUs carry an exercise price of Re. 1 (face value), while 25,433 stock options are priced at Rs. 974.45. Vesting is spread over 1 to 5 years based on performance criteria, with a portion of PSUs vesting on April 1, 2029.
Likely market impact
Minor dilution risk. Adds about 2.07 lakh shares to potential equity base over the vesting period and signals employee retention focus.